NASDAQ: SYBX - Synlogic, Inc.

छह महीने के लिए लाभप्रदता: -4.9%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Synlogic, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Synlogic, Inc.

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic and immunological diseases in the United States.

अधिक जानकारी
Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase II clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2015-10-01
ISIN US87166L1008
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.synlogictx.com
Цена ао 1.78
प्रति दिन मूल्य परिवर्तन: -3.55% (1.4101)
प्रति सप्ताह मूल्य परिवर्तन: -4.23% (1.42)
प्रति माह मूल्य परिवर्तन: -3.55% (1.41)
3 महीने में कीमत में बदलाव: -11.11% (1.53)
छह महीने में कीमत में बदलाव: -4.9% (1.43)
प्रति वर्ष मूल्य परिवर्तन: -64.68% (3.85)
3 वर्षों में मूल्य परिवर्तन: -43.57% (2.41)
5 वर्षों में मूल्य परिवर्तन: -35.85% (2.12)
10 वर्षों में मूल्य परिवर्तन: -0% (1.36)
वर्ष की शुरुआत से मूल्य परिवर्तन: -6.85% (1.46)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 7.02 1
P/BV 0.5549 10
P/E 0 0
EV/EBITDA -0.3314 0
कुल: 5.13

क्षमता

नाम अर्थ श्रेणी
ROA, % -75.82 0
ROE, % -134.29 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.3371 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 53.23 7
लाभप्रदता Ebitda, % 1.4 1
लाभप्रदता EPS, % 447.18 10
कुल: 4.2
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
NEA Management Company, LLC 2922774 25.09
Armistice Capital, LLC 1055000 9.06
FMR, LLC 258644 2.22
Vanguard Group Inc 188433 1.62
Alyeska Investment Group, L.P. 55872 0.48
Renaissance Technologies, LLC 54630 0.47
Geode Capital Management, LLC 44423 0.38
Harbor Capital Advisors, Inc. 30685 0.26
Fiduciary Trust Company (MA) 22352 0.19
Ikarian Capital, LLC 20448 0.18



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Antoine Awad Principal Executive Officer 580.33k 1980 (45 साल)
Dr. Timothy K. Lu M.D., Ph.D. Co-Founder & Member of Scientific Advisory Board N/A 1981 (44 वर्ष)
Dr. James J. Collins Ph.D. Co-Founder & Member of Scientific Advisory Board N/A 1966 (59 साल)
Ms. Mary Beth Dooley VP, Head of Finance and Principal Financial Officer & Principal Accounting Officer N/A 1981 (44 वर्ष)
Mr. Ajay Munshi Vice President of Corporate Development N/A
Ms. Molly Harper Chief Business Officer N/A 1977 (48 साल)
Dr. Neal Sondheimer M.D., Ph.D. VP & Head of Clinical N/A
Dr. Mylene Perreault Ph.D. VP & Head of Research
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Advisor 1962 (63 वर्ष)

पता: United States, Cambridge. MA, 301 Binney Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.synlogictx.com